154 related articles for article (PubMed ID: 34392955)
21. Minimally Invasive Staging of Apparent Stage I Malignant Ovarian Germ Cell Tumors: Prevalence and Outcomes.
Nasioudis D; Minis E; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
J Minim Invasive Gynecol; 2019; 26(3):471-476. PubMed ID: 29890352
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
Zhang C; Xi X
Oncol Res Treat; 2023; 46(11):476-492. PubMed ID: 37857263
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological pattern and outcome of pediatric malignant ovarian germ cell tumors: South Egypt Cancer Institute experience.
Ali A; Sayed H; Salem M; Hamdy M; Farok A
J Pediatr Surg; 2018 Apr; 53(4):837-840. PubMed ID: 28919321
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of malignant ovarian germ-cell tumors treated in Chiang Mai University Hospital over a nine year period.
Neeyalavira V; Suprasert P
Asian Pac J Cancer Prev; 2014; 15(12):4909-13. PubMed ID: 24998562
[TBL] [Abstract][Full Text] [Related]
25. A population-based analysis of 1037 malignant ovarian tumors in the pediatric population.
Brookfield KF; Cheung MC; Koniaris LG; Sola JE; Fischer AC
J Surg Res; 2009 Sep; 156(1):45-9. PubMed ID: 19592022
[TBL] [Abstract][Full Text] [Related]
26. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
Qin B; Xu W; Li Y
Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
[TBL] [Abstract][Full Text] [Related]
27. Ovarian cancer in the young.
Anteby SO; Mor-Josef S; Schenker JG
Eur J Gynaecol Oncol; 1985; 6(1):41-4. PubMed ID: 2982618
[TBL] [Abstract][Full Text] [Related]
28. Nomograms to predict the prognosis in malignant ovarian germ cell tumors: a large cohort study.
Song Z; Wang Y; Zhou Y; Zhang D
BMC Cancer; 2022 Mar; 22(1):257. PubMed ID: 35272629
[TBL] [Abstract][Full Text] [Related]
29. Malignant ovarian germ cell tumours in the post-menopausal population.
Robertson JA; Sanday K; Nicklin J
Aust N Z J Obstet Gynaecol; 2019 Apr; 59(2):285-287. PubMed ID: 30277261
[TBL] [Abstract][Full Text] [Related]
30. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
31. Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989-2015.
van der Hel OL; Timmermans M; van Altena AM; Kruitwagen RFPM; Slangen BFM; Sonke GS; van de Vijver KK; van der Aa MA
Eur J Cancer; 2019 Sep; 118():97-104. PubMed ID: 31326731
[TBL] [Abstract][Full Text] [Related]
32. Malignant ovarian germ cell tumor in King Chulalongkorn Memorial Hospital.
Lertkhachonsuk R; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Tresukosol D
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S124-8. PubMed ID: 16623016
[TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery in advanced stage malignant ovarian germ cell tumors.
Karalok A; Comert GK; Kilic C; Turkmen O; Kilic F; Basaran D; Boyraz G; Tekin ÖM; Turan T
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):461-466. PubMed ID: 31228608
[TBL] [Abstract][Full Text] [Related]
34. Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.
Stojanovic MM; Rancic NK; Andjelković Apostolović MR; Ignjatović AM; Stojanovic DR; Mitic Lakusic VR; Ilic MV
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208629
[No Abstract] [Full Text] [Related]
35. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.
Lim MC; Won YJ; Ko MJ; Kim M; Shim SH; Suh DH; Kim JW
J Gynecol Oncol; 2019 Jan; 30(1):e38. PubMed ID: 30574686
[TBL] [Abstract][Full Text] [Related]
36. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
[TBL] [Abstract][Full Text] [Related]
37. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
Choi MC; Chung YS; Lee JW; Kwon BS; Park BK; Kim SI; Shim SH; Lee KB; Seong SJ; Lee SJ; Lee SH; Yoo HJ; Song T; Kim MK; Baek MH; Kang S; Kim YM
Eur J Cancer; 2020 Jul; 133():56-65. PubMed ID: 32442924
[TBL] [Abstract][Full Text] [Related]
38. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.
Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY
J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436
[TBL] [Abstract][Full Text] [Related]
39. Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer.
dos Santos Silva I; Swerdlow AJ
Br J Cancer; 1991 May; 63(5):814-8. PubMed ID: 1645564
[TBL] [Abstract][Full Text] [Related]
40. Patterns and progress in ovarian cancer over 14 years.
Chan JK; Cheung MK; Husain A; Teng NN; West D; Whittemore AS; Berek JS; Osann K
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):521-8. PubMed ID: 16946210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
